Mirae Asset Global Etfs Holdings Ltd. Biotechnology

Mirae Asset Global Etfs Holdings Ltd.

$39.6 Billion
Q2 2024

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade	Trade History
RPRX Royalty Pharma PLC	$11.5B	$1.27 Million 0.0% of portfolio	48,190	Q2 2024 New
GERN Geron Corp	$1.61B	$1.26 Million 0.0% of portfolio	296,743	Q2 2024 New
ACLX Arcellx, Inc.	$4.52B	$1.26 Million 0.0% of portfolio	22,755	Q2 2024 New
RYTM Rhythm Pharmaceuticals, Inc.	$3.75B	$1.25 Million 0.0% of portfolio	30,391	Q2 2024 New
VCEL Vericel Corp	$2.55B	$1.23 Million 0.0% of portfolio	26,894	Q2 2024 New
IOVA Iovance Biotherapeutics, Inc.	$1.67B	$1.17 Million 0.0% of portfolio	145,760	Q2 2024 New
PTGX Protagonist Therapeutics, Inc	$2.27B	$1.11 Million 0.0% of portfolio	32,120	Q2 2024 New
ARDX Ardelyx, Inc.	$892M	$1.05 Million 0.0% of portfolio	141,341	Q2 2024 New
CPRX Catalyst Pharmaceuticals, Inc.	$2.46B	$990,000 0.0% of portfolio	63,929	Q2 2024 New
SNDX Syndax Pharmaceuticals Inc	$1.23B	$972,000 0.0% of portfolio	47,373	Q2 2024 New
ROIV Roivant Sciences Ltd.	$8.36B	$966,000 0.0% of portfolio	91,444	Q2 2024 New
MNKD Mannkind Corp	$1.89B	$961,000 0.0% of portfolio	184,243	Q2 2024 New
EDIT Editas Medicine, Inc.	$214M	$957,000 0.0% of portfolio	205,138	Q2 2024 New
VERA Vera Therapeutics, Inc.	$1.3B	$931,000 0.0% of portfolio	25,735	Q2 2024 New
IMVT Immunovant, Inc.	$3.55B	$870,000 0.0% of portfolio	32,956	Q2 2024 New
NVAX Novavax Inc	$697M	$845,000 0.0% of portfolio	66,804	Q2 2024 New
KURA Kura Oncology, Inc.	$1.18B	$833,000 0.0% of portfolio	40,484	Q2 2024 New
AKRO Akero Therapeutics, Inc.	$1.6B	$832,000 0.0% of portfolio	35,469	Q2 2024 New
MORF Morphic Holding, Inc.	$2.19B	$760,000 0.0% of portfolio	22,331	Q2 2024 New
MLTX Moon Lake Immunotherapeutics	$1.91B	$735,000 0.0% of portfolio	16,730	Q2 2024 New
KYMR Kymera Therapeutics, Inc.	$2.79B	$733,000 0.0% of portfolio	24,570	Q2 2024 New
BGNE Bei Gene, Ltd.	$21.3B	$702,000 0.0% of portfolio	4,921	Q2 2024 New
VERV Verve Therapeutics, Inc.	$378M	$702,000 0.0% of portfolio	144,027	Q2 2024 New
BCRX Biocryst Pharmaceuticals Inc	$1.45B	$701,000 0.0% of portfolio	113,527	Q2 2024 New
KROS Keros Therapeutics, Inc.	$1.75B	$693,000 0.0% of portfolio	15,183	Q2 2024 New
ARVN Arvinas, Inc.	$1.44B	$692,000 0.0% of portfolio	26,032	Q2 2024 New
LGND Ligand Pharmaceuticals Inc	$2.05B	$685,000 0.0% of portfolio	8,135	Q2 2024 New
EXEL Exelixis, Inc.	$11.7B	$650,000 0.0% of portfolio	28,942	Q2 2024 New
RXRX Recursion Pharmaceuticals, Inc.	$1.28B	$637,000 0.0% of portfolio	84,941	Q2 2024 New
XNCR Xencor Inc	$1.41B	$622,000 0.0% of portfolio	32,882	Q2 2024 New
NRIX Nurix Therapeutics, Inc.	$1.29B	$617,000 0.0% of portfolio	29,575	Q2 2024 New
ALLO Allogene Therapeutics, Inc.	$443M	$615,000 0.0% of portfolio	264,329	Q2 2024 New
MIRM Mirum Pharmaceuticals, Inc.	$1.54B	$533,000 0.0% of portfolio	15,608	Q2 2024 New
EWTX Edgewise Therapeutics, Inc.	$2.3B	$527,000 0.0% of portfolio	29,286	Q2 2024 New
DAWN Day One Biopharmaceuticals, Inc.	$1.2B	$526,000 0.0% of portfolio	38,174	Q2 2024 New
IBRX Immunity Bio, Inc.	$2.23B	$525,000 0.0% of portfolio	83,109	Q2 2024 New
FDMT 4 D Molecular Therapeutics, Inc.	$263M	$519,000 0.0% of portfolio	24,749	Q2 2024 New
PRTA Prothena Corp Public LTD CO	$831M	$511,000 0.0% of portfolio	24,804	Q2 2024 New
PSTX Poseida Therapeutics, Inc.	$264M	$505,000 0.0% of portfolio	173,112	Q2 2024 New
SMMT Summit Therapeutics Inc.	$4.31B	$505,000 0.0% of portfolio	64,818	Q2 2024 New
HRMY Harmony Biosciences Holdings, Inc.	$2.13B	$490,000 0.0% of portfolio	16,270	Q2 2024 New
INVA Innoviva, Inc.	$1.41B	$480,000 0.0% of portfolio	29,286	Q2 2024 New
RCUS Arcus Biosciences, Inc.	$1.29B	$476,000 0.0% of portfolio	31,265	Q2 2024 New
ARQT Arcutis Biotherapeutics, Inc.	$651M	$469,000 0.0% of portfolio	50,444	Q2 2024 New
JANX Janux Therapeutics, Inc.	$2.25B	$462,000 0.0% of portfolio	11,043	Q2 2024 New
LYEL Lyell Immunopharma, Inc.	$302M	$452,000 0.0% of portfolio	312,406	Q2 2024 New
TSVT 2seventy Bio, Inc.	$179M	$449,000 0.0% of portfolio	116,847	Q2 2024 New
BLUE Bluebird Bio, Inc.	$31.6M	$448,000 0.0% of portfolio	457,420	Q2 2024 New
MDXG Mimedx Group, Inc.	$855M	$441,000 0.0% of portfolio	63,774	Q2 2024 New
IMCR Immunocore Holdings PLC	$1.52B	$426,000 0.0% of portfolio	12,599	Q2 2024 New

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Etfs Holdings Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Etfs Holdings Ltd. with notifications on news.